Subtype
Rectal Neoplasm
CI-CAN-00006564Explore in graph →
Non-malignant434 active trials1 approved drugs5 evidence items
Loading cancer entity…
Subtype
CI-CAN-00006564Explore in graph →
Clinical trials
1,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02569645 | Rosuvastatin in the Treatment of Rectal Cancer | completed | Phase 2 | 45 | AHS Cancer Control AlbertaOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT00677586 | Simultaneous Versus Staged Resection for Initially Resectable Synchronous Rectal Cancer Liver-limited Metastasis | completed | N/A | 180 | Fudan UniversityOTHER | 0 | Jul 7, 2022 | clinicaltrials |
| NCT03622437 |
| Individual Follow-up After Rectal Cancer - Focus on the Needs of the Patient(FURCA) |
| completed |
| N/A |
| 336 |
| Aarhus University HospitalOTHER |
| 1 |
| Jun 14, 2022 |
| clinicaltrials |
| NCT03039595 | Ploidy and Stroma in Early Rectal Cancer | completed | — | 150 | Oxford University Hospitals NHS TrustOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT05398822 | The Role of TextRAd on Detection of Liver Metastasis in Rectal Cancer | completed | — | 113 | East Suffolk and North Essex NHS Foundation TrustOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT02935309 | Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma | completed | Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT03082495 | Exercise During and After Neoadjuvant Rectal Cancer Treatment(EXERT) | completed | N/A | 36 | University of AlbertaOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT04160650 | Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy | completed | N/A | 82 | University of TurkuOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT05388513 | Evaluating Factors Affecting Survival in Colon and Rectum Cancer | completed | — | 161 | Umraniye Education and Research HospitalOTHER_GOV | 0 | May 24, 2022 | clinicaltrials |
| NCT04443985 | A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer | completed | — | 140 | Mahidol UniversityOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT05381324 | Fistula-associated Anal Adenocarcinoma | completed | — | 1,004 | Medical University of ViennaOTHER | 0 | May 19, 2022 | clinicaltrials |
| NCT00622557 | General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)(SOCRATES) | completed | — | 200,000 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT01113736 | Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy(AlloMem) | completed | Phase 1 | 10 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT03666442 | Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer | completed | Phase 2 | 61 | West China HospitalOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT04316078 | A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies | completed | N/A | 126 | Sheba Medical CenterOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
| NCT01904656 | CBPR Strategies to Increase Colorectal Cancer Screening in Ohio Appalachia | completed | N/A | 4,509 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT05339763 | Long Term Bowel Function Following Rectal Cancer Surgery | completed | N/A | 171 | Mansoura UniversityOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT03102047 | Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer | completed | Phase 2 | 45 | NSABP Foundation IncNETWORK | 1 | Apr 20, 2022 | clinicaltrials |
| NCT03598231 | Effectiveness of Sacral Neuromodulation in Low Anterior Resection Syndrome(SANLARS) | completed | N/A | 45 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery(PIER) | completed | Phase 2 | 34 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT03931980 | Robotic Versus Laparoscopic Approach for Rectal Cancer Surgery | completed | N/A | 100 | Binh Dan HospitalOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT05274945 | Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer | completed | Phase 2 | 58 | Alexandria UniversityOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT00515853 | The Role of Biofeedback in Improving Continence After Anterior Resection | completed | N/A | 121 | University of SouthamptonOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT03688906 | AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test | completed | — | 3,275 | Freenome Holdings Inc.INDUSTRY | 2 | Mar 2, 2022 | clinicaltrials |
| NCT00308516 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | completed | Phase 2 | 66 | SCRI Development Innovations, LLCOTHER | 1 | Dec 10, 2021 | clinicaltrials |
| NCT04920435 | Prediction of the Response to Neoadjuvant Radiation Chemotherapy Through Texture Analysis Derived From Medical Imaging(RECTOMICS) | completed | — | 124 | University Hospital, BrestOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT01308190 | Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer | completed | Phase 3 | 173 | Corporacion Parc TauliOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT02550769 | Study of NOTES-TME Versus L-LAR in Rectal Cancer(NOTESvsL-LAR) | completed | N/A | 116 | Corporacion Parc TauliOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT05108753 | Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China | completed | — | 175 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Nov 5, 2021 | clinicaltrials |
| NCT01987726 | Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors | completed | — | 150 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05078515 | Multicenter Validation of the PREDICT Score | completed | — | 262 | Mansoura UniversityOTHER | 1 | Oct 14, 2021 | clinicaltrials |
| NCT03152370 | Preoperative Radiotherapy and E7046 in Rectum Cancer(PRAER 1) | completed | Phase 1 | 29 | Adlai Nortye Biopharma Co., Ltd.INDUSTRY | 3 | Oct 4, 2021 | clinicaltrials |
| NCT02665026 | Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Surgery for Rectal Cancer | completed | N/A | 250 | Huashan HospitalOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT02746224 | Reconstruction Techniques and Vascular Approach After Laparoscopic Left Hemicolectomy and Rectum Low Anterior Resection(TAHR) | completed | N/A | 64 | Institut d'Investigació Biomèdica de Girona Dr. Josep TruetaOTHER | 1 | Sep 13, 2021 | clinicaltrials |
| NCT01458509 | Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys | completed | — | 325 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT02992886 | Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly | completed | Phase 2 | 68 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT02425059 | Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT03107650 | Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer(PREMARE) | completed | — | 323 | Pere Planellas GinéOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT00040599 | Safety Study of 90Y-hMN14 to Treat Colorectal Cancer | completed | Phase 1 / Phase 2 | 72 | Gilead SciencesINDUSTRY | 5 | Aug 19, 2021 | clinicaltrials |
| NCT00041652 | Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Gilead SciencesINDUSTRY | 1 | Aug 19, 2021 | clinicaltrials |
| NCT01927497 | Biological Mesh Closure of the Pelvic Floor After Extralevator Abdomino Perineal Resection for Rectal Cancer(BIOPEX) | completed | Phase 3 | 104 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04455737 | Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision(RLF) | completed | — | 189 | Walter BrunnerOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT02860234 | Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment | completed | — | 68 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT02864849 | Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer | completed | Phase 2 | 81 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT02270606 | Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer | completed | Phase 1 | 14 | Virginia Commonwealth UniversityOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT01424293 | Fluorescent Evaluation of Colorectal Anastamoses | completed | N/A | 7 | Maimonides Medical CenterOTHER | 1 | Jul 13, 2021 | clinicaltrials |
| NCT02393755 | Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 42 | Roswell Park Cancer InstituteOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT04949672 | Pathology Assessment of Mesorectal Fascia After TME by Laparoscopic, Open, TransAnal and Robotic Approaches (LOTARTME)(LOTARTME) | completed | — | 153 | San Giovanni Addolorata HospitalOTHER | 1 | Jul 2, 2021 | clinicaltrials |
| NCT00695201 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer | completed | Phase 1 | 52 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT01902953 | Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC) | completed | Phase 2 | 16 | Maimonides Medical CenterOTHER | 1 | Jun 23, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jul 20, 2022source: clinicaltrials